Atossa Genetics (NASDAQ: ATOS) is a molecular diagnostics company developing innovative breast health products and services designed to improve breast health. The company’s laboratory developed tests (LDTs) are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The LDTs and the company’s medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, visit the company’s website at www.atossagenetics.com